Crucell Announces New Award of $110 Million for Paediatric Vaccine Quinvaxem(R) by UNICEF to Support Vaccination Programs in the Developing World LEIDEN, The ...

AMSTERDAM, Aug 17 (Reuters) - Dutch biotech group Crucell swung to a second-quarter net profit as it benefited from production problems at one of its key rivals, and it raised its full-year guidance ...

Leiden, the Netherlands (July 8, 2010) - Dutch biopharmaceutical company Crucell N.V. (NYSE Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) today announced that Crucell and sanofi pasteur reached an ...

Leiden, The Netherlands, 7 January 2009 - Dutch biopharmaceutical company Crucell N.V. (Euronext, NASDAQ: CRXL; Swiss Exchange: CRX) today confirms that it is in friendly discussions with Wyeth that ...

AMSTERDAM, April 11 (Reuters) - Dutch biotech firm Crucell will be delisted from Euronext Amsterdam after the close of trading on Monday, following its takeover by U.S. healthcare company Johnson & ...

U.S. diversified health care company Johnson & Johnson has bought an 18 percent stake in biotech firm Crucell for 302 million euros ($444 million) as part of a flu vaccine development deal, the Dutch ...

U.S. healthcare giant Johnson & Johnson (NYSE:JNJ) has launched a $2.3 billion bid to takeover vaccine maker Crucell in an effort to catapult itself into the global vaccine market. Through its newly ...

In an attempt to strengthen its presence in vaccines, Johnson & Johnson has made an offer for Dutch vaccine maker Crucell. U.S. pharmaceutical giant Johnson & Johnson (JNJ) has finally launched its ...

Dutch biotechnology company Crucell has agreed to buy Berna Biotech of Switzerland in a deal that will create a major independent vaccine company. Dutch biotechnology company Crucell has agreed to buy ...

Dutch biotech Crucell has entered into an agreement to by Sweden’s SBL Vaccin AB, boosting its portfolio of vaccines in a deal valued at around 39 million euros ($50m). Dutch biotech Crucell has ...

LEIDEN, The Netherlands, July 29, 2009 – The US-based PATH Malaria Vaccine Initiative (MVI), the United States Agency for International Development (USAID) Malaria Vaccine Development Program (MVDP), ...

TRENTON, N.J. -- Johnson & Johnson said Wednesday it is buying Holland's Crucell NV for about $2.41 billion, marking the American health care giant's latest effort to gain a big foothold in the ...